Abstract 15742: An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner

Harry J.G.M. Crijns,Jeremy N. Ruskin,Arif Elvan,Nadea Al-Windy,Ype S. Tuininga,Erik Badings,Ismail Aksoy,Isabelle C. Van Gelder,John Camm,Peter R. Kowey,Luiz Belardinelli

Abstract 15742: An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner

2020

Harry J.G.M. Crijns
Jeremy N. Ruskin
Arif Elvan
Nadea Al-Windy
Ype S. Tuininga
Erik Badings
Ismail Aksoy
Isabelle C. Van Gelder
John Camm
Peter R. Kowey
Luiz Belardinelli

Introduction: Oral and intravenous (IV) flecainide are recommended as first line therapy for pharmacological cardioversion of recent-onset atrial fibrillation (AF) in patients without known relevan...

Keywords:

Internal medicine
Sinus rhythm
Inhalation Solution
Atrial fibrillation
multicenter study
concentration dependent
Flecainide Acetate
Cardiology
Flecainide
Medicine
recent onset

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations